º»¹®/³»¿ë
7. Gallstone pancreatitis risk
5mm ¹Ì¸¸ÀÇ ÀÛÀº ´ã¼®ÀÌ Å« ´ã¼®º¸´Ù ÃéÀå¿° À§ÇèÀÌ ´õ ³ô´Ù(4¹è). ¶Ñ·ÇÇÑ ¿øÀÎ ¾ø´Â recurrent pancreatitisȯÀÚÀÇ 2/3°¡ occult gallstone disease (microlithiasis)¸¦ °®°í ÀÖ´Ù. ÀÌ·± ȯÀڵ鿡°Ô¼ duodenal aspirationÇÏ¿© cholesterol crystalÀ» Áõ¸íÇÔÀ¸·Î½á È®ÁøÇÒ ¼ö ÀÖ´Ù.
8. Pancreatitis in AIDS patient
i) infection risk (CMV, Cryptosporidium, M. avium complex)
ii) AIDSÄ¡·á¾àÁ¦ ÀÚü°¡ pancreatitis¸¦ Àß ÀÏÀ¸Å²´Ù.
(didanosine, pentamidine, bactrim)
9. Ä¡·á
1) °í½ÄÀû Ä¡·á
¨ç ´ëºÎºÐ(85-90%)°¡ 3-7Àϳ» ÀúÀý·Î ȸº¹µÈ´Ù.
pain control, IV fluid, NPO, NG suction
ÃÖ±Ù NG suctionÀº mild, moderately severe pancreatitisȯÀÚ¿¡¼ µæÀÌ ¾øÀ½ÀÌ ¹àÇôÁ³´Ù.
µû¶ó¼ ¼±ÅÃÀûÀ¸·Î »ç¿ë
anticholinergics´Â ÀûÀÀ¡¿
¨è prophylactic antibiotics
severe acute pancreatitis¿¡¼ prophylactic antibiotics¸¦ »ç¿ëÇÏ¿© ÁÁÀº °á°ú¸¦ ¾ò°í, °¨¿° ¹× »ç¸Á·üÀ» °¨¼Ò½ÃÄ×´Ù´Â º¸°í°¡ ÀÖ´Ù.
¨é È¿°ú°¡ ¾ø´Â °ÍÀ¸·Î ÆÇ¸íµÈ ¾à
glucagon, H2 blocker, protease inhibitor(aprotinin), glucocorticoid¡¦(»ý·«)
Âü°í¹®Çå
*Âü°í¹®Çå
1. Harrison¡¯s principles of Internal medicine 16th edition
2. À̼º±¸. ¸¸¼º ÃéÀå¿°ÀÇ ³»½Ã°æÀû Ä¡·á : È¿°ú¿Í ÇѰè. 2004 ´ëÇѼÒȱâÇÐȸ ½ÉÆ÷Áö¾ö
3. À̵¿±â. Àç¹ß¼º ÃéÀå¿°ÀÇ ¿øÀαԸí : ±× ´Ü°èÀû Á¢±Ù. 2004 ´ëÇѼÒȱâÇÐȸ ½ÉÆ÷Áö¾ö
4. ±èÇö¿µ ¿Ü. ¸¸¼º ÃéÀå¿°ÀÇ ÀÓ»óÀû °íÂû. ´ëÇѼÒȱâÇÐȸÁö 2002;40: 191-196.
5. Á¶¿µ´ö. ¸¸¼º ÃéÀå¿° ȯÀÚÀÇ »îÀÇ Áú. 2002 ´ëÇѼÒȱâÇÐȸ Ãá°èÇмú´ëȸ ½ÉÆ÷Áö¾ö
6. À̵¿±â. Çѱ¹Àο¡¼ ¸¸¼º ÃéÀå¿°ÀÇ ¿ªÇаú ¿øÀÎ ¹× Ä¡·á. ´ëÇѼÒȱâÇÐȸÁö 2002;39:315-323
7. ±èÀç¼±. ±Þ¼º ÃéÀå¿° ¹× ÇÕº´Áõ ¹ß»ý±âÀü. ´ëÇÑÃé´ãµµ¿¬±¸È¸ ½ÉÆ÷Áö¾ö
8. ¼µ¿¿Ï. ±Þ¼º ÃéÀå¿°ÀÇ »õ·Î¿î ½ÇÇèÀû Ä¡·á. ´ëÇÑÃé´ãµµ¿¬±¸È¸ ½ÉÆ÷Áö¾ö